Karen Prange has been an Advisor to EQT since 2020.
Until 2018, Karen was CEO Global Animal Health, Medical and Dental Surgical Group at Henry Schein and a member of the Executive Committee. Previously, she was SVP of Boston Scientific and President of its Urology and Pelvic Health business and served as General Manager of the Micrus Endovascular and Codman Neurovascular business at Johnson & Johnson. In addition to general management roles, Karen has extensive experience in commercial and operational roles, including managing innovation pipelines and acquiring and integrating companies. Today, Karen serves on the boards of Nevro, Atricure, Cantel Medical and Nuvo Group.
Karen earned her B.S. in Business Administration with honors from the University of Florida and has completed executive education coursework at UCLA Anderson School of Business and Smith College.
EQT Board Memberships
Current: Board member of WS Audiology